Medline IPO
Medline is one of the largest private medical supply companies in the U.S., manufacturing and distributing products to hospitals, surgery centers, and clinics nationwide. The company generates over $20 billion in annual revenue. Medline has been exploring an IPO that could value it at $50 billion or more.
What We Know
Medline is one of the largest private companies in the U.S. with over $20 billion in annual revenue. The company has been backed by private equity sponsors including Blackstone, Carlyle, and Hellman & Friedman since 2021. An IPO has been explored that could value Medline at $50 billion or more, but no filing has been made.
Frequently Asked Questions
Has Medline had an IPO?
As of early 2026, there is no confirmed IPO filing for Medline. There has been media speculation about a potential public listing, but the company has not made any official announcements. Sign up for alerts to get notified if Medline files for an IPO.
When is the Medline IPO date?
No Medline IPO date has been announced. While there has been speculation about a potential listing, no timeline has been confirmed. Sign up for alerts to be notified of any updates.
How can I buy Medline stock?
Medline is not yet publicly traded and there is no confirmed IPO timeline. If the company does go public, you'll be able to buy shares through any major brokerage. Sign up for alerts to stay informed.
Stay Updated on the Medline IPO
Get real-time alerts when Medline files for an IPO, prices shares, or begins trading.
Get IPO Alerts